Información de la revista
Editorial
Comment to: “Transcutaneous stimulation of the posterior tibial nerve for treating refractory urge incontinence of idiopathic and neurogenic origin”
A. Alcántara Montero, C. Müller-Arteaga
Actas Urol Esp. 2019;43:1-3
Original articles
Three-year interim results of overall and progression-free survival in a cohort of patients with prostate cancer (GESCAP group)
J.M. Cózar, B. Miñana, F. Gómez-Veiga, A. Rodríguez-Antolín
Actas Urol Esp. 2019;43:4-11
Effectiveness of the “cognitive” biopsy in the diagnosis of prostate cancer in patients with a previous negative biopsy
G. Barbas Bernardos, F. Herranz Amo, E. de Miguel Campos, A. Luis Cardo, A. Herranz Arriero, J. Caño Velasco, M.J. Cancho Gil, J. Jara Rascón, ... C. Hernández Fernández
Actas Urol Esp. 2019;43:12-7
Incidence of second tumours in high risk prostate cancer patients according to the primary treatment applied
J. Caño-Velasco, F. Herranz-Amo, G. Barbas-Bernardos, L. Polanco-Pujol, E. Lledó-García, C. Hernández-Fernández
Actas Urol Esp. 2019;43:18-25
Casuistry
Urethral reconstruction in patients previously treated with Memokath™ urethral endoprosthesis
J.C. Angulo, J. Pankaj, I. Arance, S. Kulkarni
Actas Urol Esp. 2019;43:26-31
Usefulness of PET/CT 18-FDG for the diagnosis and follow-up of urological, urothelial and kidney tumours
C. González-Ruiz de León, J. García-Rodríguez, N. Pérez-Castro, C. Vigil-Díaz, M.L. Pérez-Haro, J.M. Fernández-Gómez
Actas Urol Esp. 2019;43:32-8
New techiques and technologies
Endourological treatment of symptomatic ureteral stump posnephrectomy
B. Fernández-Bautista, A. Parente Hernández, R. Ortiz Rodríguez, L. Burgos Lucena, J.M. Angulo Madero
Actas Urol Esp. 2019;43:39-43
Surgery workshop
A new approach to laparoscopic implantation of artificial urinary sphincter: Vesicovaginal approach to the bladder neck
M. Ruiz-Hernández, L. López-Fando, J.M. Gómez de Vicente, M.A. Jiménez-Cidre, M.D. Sánchez-Gallego, J. Lorca-Álvaro, D. Díaz-Pérez, F.J. Burgos-Revilla
Actas Urol Esp. 2019;43:44-50
Letters to the editor
Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder: SYNERGY II study
A. Alcántara Montero
Actas Urol Esp. 2019;43:51-2
5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
A. Alcántara Montero, C. Müller-Arteaga
Actas Urol Esp. 2019;43:52-3